Tandem High-dose Chemotherapy and Autologous Stem Cell Rescue in Patients With High-risk Neuroblastoma
Status:
Completed
Trial end date:
2018-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and toxicity of tandem HDCT/ASCR in
children with high-risk neuroblastoma. In the present study, a single arm trial of tandem
HDCT/ASCR will be carried out. In the present study, the investigators will investigate
whether tandem HDCT/ASCR might improve the survival of patients with high-risk neuroblastoma
with acceptable toxicity.